ASML Holding N.V. vs. Marvell Technology: Which Technology Stock Is a Better Buy in 2026?

Marvell is presented as the preferred 2026 investment despite its higher valuation, supported by FY2026 revenue growth of 42.1% to $8.2B and a swing to $2.7B of net income, versus ASML's FY2025 revenue growth of 15.6% to $37.2B. Marvell trades at 62.5x forward P/E and 24.6x sales, premiums of roughly 49% and 43%, respectively, to ASML's 42.0x and 17.2x multiples. ASML remains the lower-risk choice due to its near-monopoly in advanced lithography, $12.1B in free cash flow, and lower leverage, while Marvell carries customer-concentration, competition, export-control, and stock-based-compensation risks.

Analysis

The relevant relative-value question is not AI exposure but where each company sits in the AI capex cycle. ASML monetizes leading-edge foundry capacity additions with a long order-to-revenue lag and unusually high switching costs; MRVL monetizes nearer-term architecture wins, where customer program timing and volume ramps can move estimates sharply in either direction. That makes MRVL more sensitive to a 1-3 month hyperscaler capex revision, while ASML has greater 6-18 month durability if leading-edge logic and HBM demand sustain.

MRVL's valuation premium leaves little room for a normal transition from initial custom-silicon deployment to broad production. The reported profitability inflection should be stress-tested against dilution-adjusted FCF: elevated SBC means economic cash conversion is materially weaker than headline cash flow suggests. A single large distributor or cloud customer moderating orders would create operating-deleveraging risk and multiple compression; AVGO is the natural share-gain beneficiary because it can bundle custom silicon, switching, and connectivity across a larger installed base.

ASML's apparent defensiveness is not equivalent to near-term earnings immunity. Foundry customers can defer tool acceptance even when strategic demand remains intact, shifting revenue and working-capital timing; export-control tightening could also redirect Chinese demand toward mature-node tools rather than eliminate it. The contrarian setup is that the market may be paying MRVL for AI revenue growth twice—through both elevated sales multiples and aggressive margin assumptions—while underpricing ASML's leverage to the next leading-edge node transition and High-NA adoption.

Near term, avoid treating either name as a standalone read-through on NVDA demand: custom ASIC deployments can substitute for portions of GPU demand but also require more network bandwidth, optical interconnect, and leading-edge wafer capacity. The cleaner expression is relative value, with catalysts around hyperscaler capex commentary, MRVL customer-program disclosures, ASML order intake, and any incremental U.S./Dutch export-control action.

Key Decisions for Investors

• Initiate a 3-6 month long ASML / short MRVL dollar-neutral pair on strength in MRVL. Thesis: ASML offers more durable scarcity economics at a lower growth-adjusted valuation, while MRVL must sustain exceptional revenue and margin execution to defend its premium. Target 15-25% relative return; exit if MRVL raises forward revenue guidance materially while ASML reports a meaningful order-intake shortfall.
• For directional AI exposure, prefer AVGO over MRVL for the next 1-3 earnings cycles. AVGO has greater platform breadth and is better positioned if hyperscalers consolidate custom-silicon and networking spend with fewer suppliers. Reassess if MRVL demonstrates multiple independent production-scale custom silicon wins rather than customer-concentrated ramps.
• Use ASML weakness following a quarterly shipment or booking-timing miss to build a 6-18 month position, rather than chase a near-term capex narrative. Falsifier: sustained leading-edge foundry capacity deferrals combined with further export restrictions that impair backlog conversion, not merely a quarterly revenue timing shift.
• Set alerts on MRVL for distributor inventory, customer concentration disclosures, SBC as a percentage of operating cash flow, and gross-margin progression. A deceleration in AI revenue accompanied by flat-to-down gross margin would make MRVL a higher-conviction short or put-spread candidate; absent those data, do not force the short against AI momentum.